Related by context. All words. (Click for frequent words.) 79 aMCI precursor 68 aMCI 66 elevated triglyceride levels 66 neovascular 66 diabetes mellitus DM 65 davunetide intravenous AL 65 amnestic MCI 65 Mild Cognitive Impairment 65 apolipoprotein E4 65 mild cognitive impairment 64 psoriatic arthritis PsA 64 progressive neurodegenerative disorder 64 T1DM 64 ADPKD 64 K ras mutations 64 Alzheimer disease cognitive impairment 64 Mild cognitive impairment 64 left ventricular diastolic 64 T2DM 63 hypercholesterolemic patients 63 schizophrenia CIAS 63 choroidal neovascularization CNV 63 PLX STROKE targeting 63 interleukin IL -6 63 choroidal neovascularization 63 1 diabetes T1D 63 myelofibrosis polycythemia vera 63 Ribavirin causes 63 davunetide intranasal AL 63 serum phosphate 63 recurrent glioblastoma multiforme 63 vWF 63 Haptoglobin 63 essential thrombocythemia 63 #beta HSD1 63 kidney urologic 63 homozygous familial hypercholesterolemia 63 atherogenic dyslipidemia 63 colorectal carcinoma 63 hyperphenylalaninemia HPA due 63 affective psychosis 62 Myelodysplastic syndromes MDS 62 CYT# potent vascular disrupting 62 affective psychoses 62 interleukin IL -# 62 pathological hallmark 62 VaD 62 bronchoalveolar lavage fluid 62 HER2 overexpression 62 fasting insulin 62 Hp2 2 62 aminotransferases 62 left ventricular systolic 62 basal bolus therapy 62 CC genotype 62 diabetic kidney 62 cognitively normal 62 hematologic disorders 62 familial hypercholesterolemia FH 62 hippocampal atrophy 62 fasting glucose levels 62 preserved systolic 62 NPH insulin 62 nondiabetic 62 AML MDS 62 cytopenias 62 colorectal adenoma 62 phosphorylated tau 62 neurocognitive function 62 KIBRA 62 aplastic anemia AA 62 primary immunodeficiency PI 62 euthymic patients 61 PsA 61 papillary renal cell carcinoma 61 serum IGF 61 APOE e4 61 elevated triglycerides 61 fibrous tangles 61 extrapyramidal symptoms 61 lactate dehydrogenase LDH 61 haematologic 61 Sezary syndrome 61 morphometric vertebral fractures 61 β cell 61 serum phosphorous 61 hypometabolism 61 SSc 61 comorbid anxiety 61 moderate renal impairment 61 complement inhibitor eculizumab 61 vWD 61 HNSCC 61 neuronal dysfunction 61 pDC 61 pathologic myopia 61 glycosylated hemoglobin HbA1c 61 nonalcoholic steatohepatitis 61 MMSE scores 61 macroalbuminuria 61 proliferative retinopathy 61 γ secretase 61 apolipoprotein B 61 idiopathic Parkinson disease 61 nonischemic 61 overt nephropathy 61 hyperprolactinemia 61 dapagliflozin plus 61 mixed hyperlipidemia 61 Pioglitazone 61 medial temporal 61 multi infarct dementia 61 Alzheimer disease AD 61 impaired cognition 61 monocytic 61 ApoE4 61 paricalcitol 61 mild cognitive 61 choroidal vasculopathy 61 serum calcium levels 61 motor neuron degeneration 61 myocardial infarction ventricular fibrillation 61 rs# [004] 61 shorter telomere length 61 arterial calcification 61 Primary Hypercholesterolemia 60 basal cell nevus syndrome 60 INCB# [003] 60 pancreatic adenocarcinoma 60 colorectal adenomas 60 metaglidasen 60 unresectable tumors 60 CYP#A# CYP#D# 60 MetS 60 dopaminergic therapy 60 dilated cardiomyopathy DCM 60 Neovascular AMD 60 impaired glucose metabolism 60 INVEGA ® 60 relapsed MM 60 Glucocorticoids 60 thyrotropin levels 60 Chronic ITP 60 autoantibody positive 60 gamma secretase inhibitor 60 CLA supplementation 60 inducible nitric oxide synthase 60 intravascular hemolysis 60 Myelodysplastic Syndrome MDS 60 metformin sulfonylurea 60 gastric carcinoma 60 fibrotic disease 60 Endothelial dysfunction 60 plasma lipids 60 androgen depletion 60 Neovascular Age Related Macular 60 receptor inhibitor 60 systemic lupus erythematosus SLE 60 neutrophil counts 60 glycated hemoglobin levels 60 underlying vasculopathy 60 CIMZIA ™ 60 hippocampal function 60 Diabetic neuropathy 60 liver histology 60 Sjögren syndrome 60 urinary N telopeptide 60 systemic amyloidosis 60 nondiabetic patients 60 diastolic function 60 hematopoietic cancers 60 ADAS Cog 60 proliferative diabetic retinopathy 60 hepatorenal syndrome 60 prostate carcinogenesis 60 nonalcoholic steatohepatitis NASH 60 anti inflammatory cytokine 60 mild renal insufficiency 60 serum urate levels 60 growth hormone secretion 60 advanced adenoma 60 Lupus nephritis 60 Relapsing remitting MS 60 serum leptin 60 cAMP signaling 60 mGluR2 NAM 60 parkinsonian 60 pathophysiological effects 60 Ischemic 60 Non Alcoholic Steatohepatitis 60 CTAP# Capsules 60 Hypertrophy 60 p# biomarker 60 hsCRP levels 60 SGPT 60 HAQ DI 60 cardiac dysfunction 60 carotid artery intima media 60 familial ALS 60 transthyretin amyloidosis 60 Chronic pancreatitis 60 leukemia AML 60 glycosylated hemoglobin levels 60 microalbuminuria 60 hypoperfusion 60 Posiphen 60 hyper IgE syndrome 60 herpes zoster shingles 60 acute myelogenous leukemia AML 60 cause cardiac channelopathies 60 hyperphosphorylation 60 eosinophilic asthma 60 Insulin resistance 60 neovascular form 60 Non inferiority 60 Alzheimer disease vascular dementia 60 poststroke 60 debilitating neurodegenerative disorder 60 familial amyloidotic polyneuropathy FAP 60 naturally occurring neuroprotective 60 Leukemias 59 impaired glucose tolerance 59 C1 INH deficiency 59 hyperglycaemia 59 transaminase levels 59 Hyperlipidemia 59 intermittent claudication 59 ADAMTS# 59 GRNOPC1 contains 59 neurofibrillary tangles 59 paroxysmal nocturnal hemoglobinuria 59 abnormal lipid 59 Vascular dementia 59 carotid plaque 59 MADRS score 59 renal fibrosis 59 thiazolidinedione TZD 59 p# activation 59 arterial thickening 59 prefrontal cortical 59 2 diabetes T2D 59 induce orthostatic hypotension 59 SGS# 59 brain lesions 59 hippocampal volumes 59 hepatocellular carcinomas 59 N telopeptide 59 microvascular disease 59 GH deficiency 59 cognitive function 59 LPS induced 59 atypical hyperplasia 59 isoenzyme 59 gastrin analogue TT 59 neurodevelopmental outcome 59 amyloid pathology 59 chronic thromboembolic pulmonary 59 BRAF V#E 59 APOE ε4 59 APOE4 59 primary hyperparathyroidism 59 HIV HCV coinfected 59 monoclonal gammopathy 59 hyperinsulinemia 59 Scale EDSS 59 aspartate aminotransferase AST 59 thyrotropin 59 fasting plasma glucose 59 levodopa therapy 59 NATRECOR R 59 nutlin 3a 59 Cystatin C 59 aminotransferase levels 59 advanced adenomas 59 chromosome #p# [002] 59 PSADT 59 baseline HbA1c 59 amnestic 59 neuropathological 59 onset diabetes mellitus 59 Thiazolidinediones 59 sporadic ALS 59 non constipating irritable 59 geographic atrophy 59 impaired renal 59 thiazolidinediones TZDs 59 pharmacodynamic PD 59 venlafaxine XR 59 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 59 hepatic fibrosis 59 chronic myeloid 59 pancreatic endocrine 59 prolonged QT interval 59 clinically meaningful reductions 59 thrombocytopenic patients 59 low ptau levels 59 SHPT 59 epilepsy Parkinson disease 59 lymphocytosis 59 riociguat 59 ERK1 2 59 infantile onset 59 memantine Namenda 59 HIF 1a 59 5 hydroxytryptamine 59 Alzheimer Disease Assessment 59 desvenlafaxine succinate 59 dizziness imbalance 59 normotensive 59 hyperhomocysteinemia 59 LV dysfunction 59 dysbindin gene 59 synaptic function 59 macrovascular disease 59 lesional 59 DNA methylation patterns 59 dyskeratosis congenita 59 dysglycemia 59 PAOD 59 Acute myeloid leukemia 59 fasting blood glucose 59 myeloproliferative neoplasms 59 completely resected 59 Tasimelteon 59 highest tertile 59 vaso occlusive crisis 59 erlotinib Tarceva ® 59 coronary endothelial 59 JAK2 enzyme 59 lipid parameters 59 chemoresistant 59 pCR 59 delta gamma agonist 59 Natalizumab 59 glucose homeostasis 59 neurotrophic 59 serum BDNF 59 Leber Congenital Amaurosis LCA 59 hematologic toxicity 59 amyloid beta plaques 59 selective modulator 58 albiglutide 58 autoantibody levels 58 smoldering myeloma 58 diabetes mellitus T2DM 58 infarcts 58 autonomic dysfunction 58 dysfunction LVSD 58 serum PTH 58 Malignant Glioma 58 generalized epilepsy 58 APOE gene 58 macular edema secondary 58 serum triglycerides 58 STRIDE PD 58 Glioblastoma Multiforme GBM 58 ERK signaling 58 plasma leptin 58 Diabetic nephropathy 58 inhibit oxidative stress 58 APTIVUS r 58 dyslipidemia abnormal 58 thyrotoxicosis 58 Atherosclerotic 58 recurrent VTE 58 thrombocytopenia neutropenia 58 LRP5 58 CYP#C# [002] 58 oral antidiabetic medication 58 LRAT 58 somatostatin analog 58 hypophosphatemia 58 olmesartan 58 TTR amyloidosis 58 Wernicke Korsakoff syndrome 58 ß amyloid 58 PTPN# 58 demyelination 58 decompensated liver disease 58 microcirculatory improvement helping 58 renal cell carcinomas 58 Alzheimer Disease AD 58 vascular occlusive diseases 58 periventricular 58 CIMZIA TM certolizumab pegol 58 HOMA IR 58 T2D 58 autoimmune encephalitis 58 AGILECT R 58 transthyretin 58 gastric carcinogenesis 58 castrate resistant prostate cancer 58 serum insulin 58 Severe Primary IGFD 58 glucose intolerance 58 protein tyrosine phosphatase 1B 58 Low density lipoprotein 58 Hodgkin lymphoma HL 58 serum phosphate levels 58 myeloproliferative diseases 58 endothelial activation 58 albumin excretion 58 MS relapses 58 RRM1 58 erythematosus SLE 58 contractile function 58 postoperative AF 58 experimental autoimmune encephalomyelitis 58 hepatic enzymes 58 grade cervical intraepithelial 58 preserved ejection fraction 58 histologic subtype 58 elevated fasting glucose 58 CYP#A# substrate 58 urothelial 58 white matter hyperintensities 58 nondemented 58 euthyroid 58 familial hypercholesterolemia 58 endometrial hyperplasia 58 axonal damage 58 vasogenic edema 58 diabetes dyslipidemia 58 Leydig cell 58 TNF antagonist 58 protein tau 58 Cutaneous T 58 insulin secreting beta 58 embolic stroke 58 congenital deficiency 58 neuron degeneration 58 metabolic acidosis 58 hypokalemia hypomagnesemia 58 alanine aminotransferase 58 pulmonary hypertension PH 58 de novo AML 58 mTOR mammalian target 58 gastrointestinal GI motility disorders 58 glial tumors 58 comorbid depression 58 baseline serum creatinine 58 MTHFR 58 minimally symptomatic 58 TEAEs 58 dyskinesia PD LID 58 colorectal liver metastases 58 Obstructive sleep apnea OSA 58 artery stenosis 58 gastric adenocarcinoma 58 relapsing remitting MS RRMS 58 MGUS 58 hepatic steatosis 58 HER2 expression 58 prostate cancer CaP 58 lactate dehydrogenase 58 potassium sparing diuretics 58 Apolipoprotein B 58 autoregulation 58 leukemia ALL 58 hypercalciuria 58 hepatic lipase 58 Davunetide 58 estrogen receptor negative 58 bronchial hyperresponsiveness 58 systolic function 58 endosomal release 58 macrovascular complications 58 apo B 58 hypercholesterolemia 58 secondary hyperparathyroidism 58 natriuresis 58 amyloid plaque formation 58 plasma kallikrein 58 smoldering multiple myeloma 58 hematological malignancy 58 cortical thinning 58 glycosylated hemoglobin 58 Sapacitabine 58 Hypotension 58 dyslipidaemia 58 antioxidant supplementation 58 mucosal healing 58 triglyceride concentrations 58 SOD2 gene 58 Peripheral arterial disease 58 vascular endothelial 58 triacylglycerol 58 plasma folate 58 HMG CoA reductase inhibitors 58 MLH1 58 impaired endothelial 58 D aspartate NMDA receptor 58 cell adhesion molecule 58 APOE allele 58 apolipoprotein E APOE 58 atherosclerotic lesions 58 diffuse gastric 58 fetuin 58 ABCB1 58 diabetic microvascular complications 58 nerve degeneration 58 malignant prostate 58 GSTT1 58 recurrent NSCLC 58 proliferator activated receptor 58 isolated systolic hypertension 58 soluble tumor necrosis 58 HbF 58 tolvaptan 58 beta amyloid peptide 58 Coronary artery calcification 58 Intravenous immunoglobulin 58 monocyte chemoattractant protein 57 lupus erythematosus 57 diabetic retinopathy DR 57 adverse cytogenetics 57 hepatocellular 57 Critical Limb Ischemia CLI 57 carcinoembryonic antigen 57 elevated IOP 57 amyloid deposition 57 Brodmann Area 57 Health Assessment Questionnaire 57 fasting plasma glucose FPG 57 Parkinson disease PD 57 pheochromocytoma 57 LHON 57 Hashimoto thyroiditis 57 severe renal impairment 57 IgA deficiency 57 ursodeoxycholic acid 57 VADT 57 HBeAg negative patients 57 neuronal plasticity 57 IBS C 57 UCP2 57 Namenda ® 57 E selectin 57 NR2B selective 57 non alcoholic steatohepatitis 57 pancytopenia 57 haematopoietic 57 Primary endpoints 57 TNFalpha 57 diabetic dyslipidemia 57 Ankylosing spondylitis 57 Angiotensin converting enzyme 57 hypercalcemia 57 PCa 57 variable ptau levels 57 gallstone disease 57 MMP2 57 Erectile function 57 neuropathic pain metabolic diseases 57 SOD1 gene 57 folic acid folate 57 atherosclerotic disease 57 autoimmune thyroid 57 lymphocyte counts 57 subarachnoid hemorrhage SAH 57 GRNCM1 57 prospectively defined 57 PDGFR 57 Abeta# 57 adrenocortical cancer 57 Hematologic 57 Alzheimer pathology 57 cell lymphoma CTCL 57 cerebral ischemia 57 Tasigna prolongs 57 atrophic gastritis 57 orally bioavailable mimics 57 Systemic lupus 57 rheumatoid arthritis lupus 57 CrCl 57 hypoxia inducible factor 57 posterior cingulate 57 Hurthle cell 57 SGOT 57 adenomatous polyps 57 immunodeficiencies 57 intracranial hemorrhage ICH 57 parathyroid carcinoma 57 certain protein tyrosine 57 Erythropoietic therapies may 57 tarenflurbil 57 DITPA 57 vitamin B# folic acid 57 post herpetic 57 OADs 57 intima media thickness 57 neurodegenerative disorder characterized 57 Secondary Hyperparathyroidism 57 LY# [003] 57 Von Willebrand 57 kainate 57 decompensated heart failure 57 systemic fungal infections 57 pathologic fractures 57 HbA1c levels 57 plasma triglycerides 57 pancreatic islet beta 57 KRAS mutations occur 57 Chronic Myeloid Leukemia 57 A1PI 57 exocrine 57 IDDM 57 elevated uric acid 57 microglial activation 57 Glioblastoma multiforme GBM 57 retinal vein occlusion 57 serum triglyceride levels 57 hypereosinophilic syndrome 57 hydroxymethyl coenzyme 57 Gleevec resistant 57 salmeterol HFA MDI 57 baroreflex 57 catechol O methyltransferase 57 dermatologic reactions 57 muscular dystrophy cystic fibrosis 57 vascular reactivity 57 vascular cognitive impairment 57 neuroinflammatory 57 recurrent genital herpes 57 subependymal giant cell 57 renal allograft 57 DQB1 * 57 chronic renal disease 57 PKC beta 57 CaM kinase II 57 alanine aminotransferase ALT 57 diabetes mellitus 57 symptomatic VTE 57 chronic eosinophilic leukemia 57 psychosocial functioning 57 urate levels 57 extracellular dopamine 57 heterozygotes 57 ATTR PN 57 asymptomatic carotid stenosis 57 hemoglobin A1c HbA1c 57 elevated LDH 57 humanin 57 prostate cancer PCa 57 relapsing remitting 57 hamartomas 57 neutropenia thrombocytopenia 57 fulminant hepatitis 57 CIPN 57 primary generalized tonic 57 extrapyramidal symptoms EPS 57 allogeneic HSCT 57 triiodothyronine 57 Cholinesterase Inhibitors 57 epithelioid 57 vascular inflammation 57 inherited retinal degeneration 57 metastatic malignant 57 pioglitazone HCl 57 acute mania 57 glomerular filtration 57 allogeneic epidermal 57 esophageal squamous cell carcinoma 57 TLR3 57 nonfasting triglyceride levels 57 microglial 57 atypical hemolytic uremic syndrome 57 follicle stimulating hormone FSH 57 CP CPPS 57 oral antidiabetes 57 renal artery stenosis 57 neurologic complications 57 metabolic abnormalities 57 vascular endothelial dysfunction 57 cognitive impairment 57 leukemia myeloma 57 Subarachnoid hemorrhage 57 carotid IMT 57 hippocampal volume 57 Arrhythmogenic Right Ventricular Cardiomyopathy 57 hemolytic anemia 57 hypothalamic pituitary adrenal axis 57 idiopathic thrombocytopenic purpura ITP 57 left ventricular hypertrophy 57 HbA 1c levels 57 Etanercept 57 Frontotemporal Dementia 57 adrenal function 57 elevated ALT 57 ADAS cog 57 cardiolipin 57 sustained ventricular tachycardia 57 apoE4 57 Platinol ® cisplatin 57 APOE e4 gene 57 histologically confirmed 57 dysbindin 57 coagulation parameters 57 RIP1 57 accumulate preferentially 57 ENPP1 57 Leber congenital amaurosis LCA 57 supratentorial 57 Heterozygous Familial Hypercholesterolemia 57 VEGF inhibitors 57 UCP1 57 Polyneuropathy 57 Retinitis pigmentosa 57 #q# deletion syndrome 57 nitric oxide synthase 57 Lewy bodies DLB 57 HDL C 57 Clusterin 57 alpha folate receptor 57 klotho 57 CSF biomarkers 57 Undesirable alterations 57 hypermethylated 57 leptin deficiency 57 amisulpride 57 Montgomery Asberg Depression 57 hypercoagulable 57 adipogenic 57 serum creatinine levels 57 metabolic disturbances 57 typical antipsychotics 57 chronic renal insufficiency 57 candesartan cilexetil 57 primary hypercholesterolemia 57 Systemic lupus erythematosus SLE 57 parkinsonian symptoms 57 stratifying patients 57 T2 lesions 57 unstable angina UA 57 serum clusterin levels 57 β amyloid 57 serum sodium 57 Mg Usa 57 Hepatocellular Carcinoma HCC 57 glulisine 57 ZOLINZA 57 neuritic 57 Cholinesterase inhibitors 57 M1 macrophages 57 steatosis 57 Darapladib 57 macrophage colony stimulating 57 Subgroup analysis 57 obstructive coronary 57 osteosarcomas 57 radiographic findings 57 Genetic variants 57 cardiac repolarization 57 Relapsing Multiple Sclerosis 57 Tolvaptan 57 cortical dysplasia 57 allogeneic bone marrow 56 heterotaxy 56 microbleeds 56 common disabling neurological 56 parkinsonism 56 progressive neurodegenerative 56 fasting hyperglycemia 56 NPHP 56 squamous cell lung cancer 56 Insulin sensitivity 56 secretory phospholipase A2 sPLA2 56 IL 1ß 56 interstitial fibrosis 56 GSTP1 56 idiopathic PD 56 cortisol synthesis 56 microangiopathy 56 carbohydrate metabolism 56 unfavorable cytogenetics 56 PCNSL 56 undergoing coronary artery 56 rheumatoid factor 56 neuritic plaques 56 corticosteroid dose 56 central adiposity 56 intracerebral haemorrhage 56 Hemorrhagic stroke 56 androgen independent 56 juvenile idiopathic arthritis 56 cardiovascular disease hypertension 56 abnormal glucose metabolism 56 AAT deficiency 56 aortic valve stenosis 56 capillary density 56 neovascularization 56 lateral orbitofrontal cortex 56 factor HGF 56 fatty acid oxidation 56 diabetes mellitus NIDDM 56 EXJADE 56 Vidaza ® 56 metformin sulfonylureas 56 anticholinergics 56 vasomotor symptoms 56 TNF Tumor Necrosis Factor 56 inverse agonist 56 resistin 56 remyelination 56 systolic dysfunction 56 Rheumatoid Arthritis RA 56 primidone 56 bone resorption 56 elevated serum creatinine 56 cortical atrophy 56 plasma lipid 56 neurocognitive impairment 56 severely active polyarticular 56 tau pathology 56 efalizumab 56 Scale cognitive subscale 56 intracranial atherosclerosis 56 Unified Parkinson Disease 56 plasminogen activator inhibitor 56 primary aldosteronism 56 nondepressed 56 abnormal p# 56 anterior uveitis 56 alpha1 antitrypsin deficiency 56 BCG refractory carcinoma 56 HGPIN 56 temporoparietal 56 soluble CD# ligand 56 elevated LDL cholesterol 56 type 1diabetes 56 virologic response 56 serum urate 56 CTEPH 56 aspartate aminotransferase 56 Anti VEGF 56 APOC3 56 Hypercholesterolemia 56 underwent coronary angiography 56 creatinine levels 56 intravenous bisphosphonates 56 pancreatic alpha 56 systemic autoimmune 56 cognitive functioning 56 isoprostane 56 Venous thromboembolism 56 subcortical 56 ischemia induced 56 hemoglobin A1c levels 56 XLHED 56 chronic lymphocytic leukemia CLL 56 mdx mice 56 myoclonus 56 Uncontrolled hypertension 56 CDKN2A 56 GABAergic interneurons 56 akinesia 56 experimentally induced 56 pulmonary exacerbations 56 endothelial dysfunction 56 idiopathic thrombocytopenic purpura 56 nephropathy 56 neurocognitive deficits 56 cholelithiasis 56 5 HT2C receptor 56 alkaline phosphatase 56 transthyretin TTR 56 nonsmall cell lung cancer 56 progressive dyspnea 56 inhibitory neurotransmitters 56 kidney insufficiency 56 allodynia 56 intravesical therapy 56 Impaired Glucose Tolerance 56 5 HT4 56 symptomatic hypotension 56 juvenile idiopathic arthritis JIA 56 NSCLC tumors 56 bezafibrate 56 follicular lymphoma FL 56 DFMO 56 idiopathic PAH 56 NNT = 56 ventricular dilation 56 refractory gout 56 opioid naive 56 HbA1C levels 56 oxidative stress markers 56 leptin concentrations 56 ejection fractions 56 HBeAg negative 56 cancer cachexia 56 Atopic eczema 56 neuronal function 56 hepatic insufficiency 56 ptau 56 multivariate Cox 56 clinically detectable 56 underwent resection 56 cystic fibrosis chronic pancreatitis 56 hepatic function 56 Major depressive disorder 56 Endothelial function 56 Brugada syndrome 56 tic severity 56 chronic progressive neurodegenerative 56 protein excretion 56 SHANK3 56 NPM1 mutation 56 ANCA associated 56 metastatic neuroendocrine tumors 56 Colon polyps 56 tryptophan depletion 56 neurosensory 56 TGFβ 56 Ophena TM 56 â ‰ ¥ 56 VKORC1 56 Aß 56 cardiac autonomic 56 serum folate 56 metabolic parameters 56 subsyndromal 56 progressive PsA 56 neuropsychiatric disorder 56 pigmented layer 56 occlusion CRVO 56 pharmacodynamic parameters 56 hypercholesterolaemia 56 diabetic nephropathy 56 adjunctive ABILIFY 56 mg BID dose 56 androgen deprivation 56 STAT3 signaling 56 constipation OIC 56 hematological parameters 56 transplantation HCT 56 lipoprotein Lp 56 atherothrombotic events 56 MMSE score 56 retinal ischemia 56 narcolepsy cataplexy 56 gastrointestinal motility 56 mRNA expression 56 NASH Huntington 56 JMML 56 cisplatin resistant 56 umol L 56 CCR5 delta# 56 amyloid β 56 deCODE AF TM 56 multiple myeloma MM 56 MEK ERK 56 tardive dyskinesia TD 56 aminotransferase ALT 56 leukemia CML 56 vulvovaginal atrophy 56 thrombocytosis 56 systemic lupus erythematosus 56 IL 1Ra 56 torsade de pointes 56 histological subtype 56 autoinflammatory diseases 56 thymidylate synthase TS 56 florbetaben 56 Hypoactive Sexual Desire Disorder 56 TGF ß1 56 cerebral infarction 56 Aortic stenosis 56 QTc prolongation 56 synovial cells 56 MELAS 56 troponin T 56 glutamic acid decarboxylase 56 mGluR4 activation 56 MYH9 gene 56 CANCIDAS 56 MALT lymphoma 56 FGF2 56 Oxidative damage 56 OSAHS 56 CYP#C# [001] 56 acute GvHD 56 cytopenia 56 Cathepsin B 56 Pulmonary hypertension 56 Chronic Lymphocytic Leukemia CLL 56 transgenic mouse models 56 KRAS mutation 56 intestinal polyps 56 hyperoxaluria 56 nausea vomiting headache 56 Thrombocytopenia 56 chronic HCV infection 56 TGF b 56 T#I [002] 56 erythropoietic 56 MAPK pathway 56 Cholangiocarcinoma 56 rs# [002]